- Home
- » Tags
- » Pegfilgrastim
Top View
- ZIEXTENZO (Pegfilgrastim-Bmez) Is Biosimilar* to NEULASTA® Discontinue ZIEXTENZO in Patients with Serious Allergic Reactions
- INN Working Document 05.179 Update December 2010
- And G-CSF (filgrastim) After Cyclophosphamide (4 G/M2) Enhance the Peripheral Blood Progenitor Cell Harvest: Results of Two Randomized Studies Including 120 Patients
- Neulasta, INN-Pegfilgrastim
- Oncology Drug Reference Guide
- Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
- FILGRASTIM, PEGFILGRASTIM, LIPEGFILGRASTIM SYNONYMS Rg-CSF
- Are All Gfs Equal? How Say I?
- Nyvepria; INN-Pegfilgrastim
- White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
- Lumicera Specialty Drug List
- (G-Csfs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim): New Warning Regarding Aortitis
- Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
- Clinical Medication Policy
- Medications Used in Sarcoma Treatment
- Clinical Medical Policy
- Integrated Safety Profile of Selinexor in Multiple Myeloma
- White Blood Cell Growth Factors
- Human Granulocyte-Colony Stimulating Factor (G-CSF)/Stem Cell Factor (SCF) Fusion Proteins: Design, Characterization and Activity
- Risk and Consequences of Chemotherapy-Induced Thrombocytopenia in US Clinical Practice
- A Randomized Study Comparing Filgrastim Versus Lenograstim Versus Molgramostim Plus Chemotherapy for Peripheral Blood Progenitor
- Pegfilgrastim, a Sustained-Duration Form of Filgrastim, Significantly
- The Incidence and Clinical Features of Pegylated Filgrastim-Induced Acute
- Pegfilgrastim, ( Neulasta), Amgen Incorporated
- Pegfilgrastim
- Therapeutic Administration of Pegfilgrastim Instead of Prophylactic Use
- Colony Stimulating Factors
- HEMATOPOIETIC AGENTS;GROWTH FACTORS,MINERALS and VITAMINS Phr.Volkan KAHRAMAN HGF’S
- Pegfilgrastim), Leukine® (Sargramostim), Granix (Tbo-Filgrastim
- Catalytic Receptors
- Lonquex, INN-Lipegfilgrastim
- Colony Stimulating Factors – Pegfilgrastim: Neulasta®; Fulphila™; Udenyca®; Ziextenzo™; Nyvepria™
- Investigator-Initiated Trial PROTOCOL INFORMATION Study Title
- Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care That Enables Cure
- Cost-Effectiveness and Budgetary Impact of Lipegfilgrastim for The
- Neupogen, Neulasta, Nivestym, Fulphila, Udenyca, Ziextenzo
- Romiplostim (Nplate ) As an Effective Radiation Countermeasure to Improve Survival and Platelet Recovery in Mice
- Please Refer to Figure 3 in Main Manuscript
- Pegfilgrastim (Neulasta)
- 3.2.2 Granulocyte-Colony Stimulating Factors, Pulmonary Haemorrhage
- Radioprotective/Mitigative Effects of Thrombopoietin Receptor Agonists
- The Effects of Granulocyte Colony-Stimulating Factor on MR Images of Bone Marrow
- Nplate (Romiplostim) for Injection Is Supplied As a Sterile, Preservative-Free, Lyophilized, Solid White Powder for Subcutaneous Injection
- Role of Lipegfilgrastim in the Management of Chemotherapy-Induced Neutropenia
- Effects of Pegfilgrastim on Normal Biodistribution of 18F-FDG: Preclinical and Clinical Studies
- Pegfilgrastim (Neulasta) Reference Number: CP.PHAR.296 Effective Date: 12/16 Coding Implications Last Review Date: 11/16 Revision Log
- Novel Agents and Approaches for Stem Cell Mobilization in Normal Donors and Patients
- White Blood Cell Colony Stimulating Factors – Commercial Medical Benefit Drug Policy
- Original Article a Comparative Analysis Between Pegfilgrastim And
- Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies
- Case Report Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
- STEM CELL BIOLOGY and HEMATOPOIETIC GROWTH FACTORS David J
- Pegfilgrastim– Breast Cancer
- 1 Poll Everywhere Audience Response Disclosures
- Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile
- Efficacy and Safety of Lipegfilgrastim Versus Pegfilgrastim